Skip to main content
OpenTrials

Clinical trial condition

Hemoglobinopathies

Explore clinical trials studying Hemoglobinopathies. Study availability and eligibility vary by location and protocol.

79 public trials 23 recruiting studies
Refine in advanced search Browse all conditions

Hemoglobinopathies trial results

Active, Not Recruiting

A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS)

NCT04624659

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +12 more
Locations
  • Univ of Alabama Birmingham Birmingham, Alabama, United States
  • Phoenix Children's Hsptl Phoenix, Arizona, United States
  • [Legal] Woodland International Research Group, LLC Little Rock, Arkansas, United States
  • [Legal] Collaborative Neuroscience Network, LLC Long Beach, California, United States
View all 142 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (TD) Anemia Associated With Myelodysplastic Syndromes (MDS) & Beta-thalassemia (β-Thal) in India

NCT05891249

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations
  • Local Institution - 0002 Ahmedabad, Gujarat, India
  • Local Institution - 0001 New Delhi, National Capital Territory of Delhi, India
  • Local Institution - 0007 Kolkata, West Bengal, India
  • Local Institution - 0005 Assam, India
View Trial Details
Active, Not Recruiting

EDIT-301 for Autologous Hematopoietic Stem Cell Transplant (HSCT) in Participants With Transfusion-Dependent Beta Thalassemia (TDT)

NCT05444894

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +10 more
Locations
  • University of California San Francisco Oakland, California, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • Columbia University Medical Center - Department of Pediatrics New York, United States
  • Columbia University Medical Center New York, United States
View Trial Details
Active, Not Recruiting

A Study Evaluating the Safety and Efficacy of EDIT-301 in Participants With Severe Sickle Cell Disease (RUBY)

NCT04853576

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • UCSF Benioff Children's Hospital Oakland, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Smilow Cancer Hospital New Haven, Connecticut, United States
  • Johns Hopkins All Children's Hospital St. Petersburg, Florida, United States
View all 24 locations
View Trial Details

Related conditions